Skip to search boxSkip to navigationSkip to main content

Potential value of vitamin E in cancer patients with venous access devices

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

<p>Background: Vitamin E has antiplatelet, fibrinolytic and endotoxin properties that may help avoid the problems of occlusion or inability to withdraw blood from port VADs. Purpose: Disseminate information about the non-traditional therapeutic use of vitamin E associated with care of Venous Access Devices (VAD) in patients with cancer. Methodology: In-person focus groups. Sample of 22 cancer patients who had port Venous Access Devices (VAD). Findings: Fourteen percent (N = 3) of patients felt that taking vitamin E, 400 -800 IU per day orally, in capsule form, avoided the problems of occlusion or inability to withdraw blood from their current VAD. Practice Implications: The effects of vitamin E on occlusion and inability to withdraw blood in caring for patients who have port VADs, requires further investigation.</p>

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 71-73 (3 pages)

Journal (Volume, Issue Number)

JAVA - Journal of the Association for Vascular Access (Volume 13, Issue 2)

Publication milestones

  • Published - 2008

Publication status

Published - 2008

ISSN

1552-8855

Publication IDs

  • Scopus: 47549093192

Publication metrics

Metrics

Fractional count
2
Fractional count
0.50
Fractional count
2
Fractional count
0.50
Fractional count
2
Fractional count
1